<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03599141</url>
  </required_header>
  <id_info>
    <org_study_id>20180519</org_study_id>
    <secondary_id>U54MD002265-11</secondary_id>
    <nct_id>NCT03599141</nct_id>
  </id_info>
  <brief_title>Testing TRUST Depression Management Intervention</brief_title>
  <acronym>TRUST</acronym>
  <official_title>Pilot RCT to Evaluate the Effects of a Trust-Building Depression Management Intervention on Moderate Depressive Symptoms in Low-Income Adolescents</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Case Western Reserve University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute on Minority Health and Health Disparities (NIMHD)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Case Western Reserve University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study evaluates the effectiveness of a novel depression management intervention in
      adolescents with depression. Half of participants will receive a traditional depression
      management intervention, wile the other half will receive the novel depression management
      intervention.
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">October 1, 2018</start_date>
  <completion_date type="Anticipated">April 30, 2021</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Patient Health Questionnaire-9 (PHQ-9) [Depressive symptoms]</measure>
    <time_frame>From Baseline to 3 months and 6 months</time_frame>
    <description>Change in total summed score on PHQ-9. Higher scores indicate greater depressive symptoms. Range is 0-27.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Youth Quality of Life scale</measure>
    <time_frame>From Baseline to 3 monhts and 6 months</time_frame>
    <description>Change in total summed and transformed score on the Youth Quality of Life scale. The response scale ranges from 0 = not at all to 10 = a great deal or completely. The scores are summed and then transformed to a 0 to 100 scale, with a higher score representing a higher quality of life.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adolescent Sleep Hygiene Scale</measure>
    <time_frame>From Baseline to 3 months and 6 months</time_frame>
    <description>Change in mean score of all items in each subscale of the Adolescent Sleep Hygiene Scale. Higher scores indicate better sleep hygiene. Range is 1-6.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adolescent Lifestyle Questionnaire Stress management subscale</measure>
    <time_frame>From Baseline to 3 months and 6 months</time_frame>
    <description>Change in total summed score on stress management sub-scale of the Adolescent Lifestyle Questionnaire. Higher scores indicate better stress management. Range is 4-20.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Extent of Medication Non-Adherence scale (Medication adherence)</measure>
    <time_frame>From Baseline to 3 months and 6 months</time_frame>
    <description>Change in total summed score on the Extent of Medication Non-Adherence scale. Higher scores indicate greater levels of nonadherence. Range is 3-15.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hill-Bone Compliance Scale (Appointment keeping)</measure>
    <time_frame>From Baseline to 3 months and 6 months</time_frame>
    <description>Change in total summed score on Hill-Bone Compliance Scale. Range is 9-36, with lower scores indicating greater appointment keeping.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">16</enrollment>
  <condition>Depression</condition>
  <condition>Quality of Life</condition>
  <arm_group>
    <arm_group_label>Depression Management</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>8 weekly group sessions</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Trust-building Self-management Together</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>8 weekly group sessions</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Trust-building Self-management Together</intervention_name>
    <description>Trust building plus depression self-management</description>
    <arm_group_label>Trust-building Self-management Together</arm_group_label>
    <other_name>TRUST</other_name>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Depression Management</intervention_name>
    <description>Traditional depression self-management</description>
    <arm_group_label>Depression Management</arm_group_label>
    <other_name>DM</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Lives in the Cleveland metro area

          -  Ages 14-17 years old

          -  Reports moderate depressive symptoms

          -  Able to read, speak, and understand the English language

        Exclusion Criteria:

          -  Current suicide risk

          -  Diagnosis with bipolar disorder, schizophrenia, or a personality disorder

          -  Severe behavioral problems that preclude group participation (as reported by parent)

          -  Family plans to move from the region within 6 months
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>14 Years</minimum_age>
    <maximum_age>17 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Case Western Reserve University</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44106</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>June 5, 2018</study_first_submitted>
  <study_first_submitted_qc>July 23, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">July 26, 2018</study_first_posted>
  <last_update_submitted>July 14, 2020</last_update_submitted>
  <last_update_submitted_qc>July 14, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 16, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Case Western Reserve University</investigator_affiliation>
    <investigator_full_name>Heather K. Hardin, PhD, RN</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <keyword>adolescent</keyword>
  <keyword>parent</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Depression</mesh_term>
    <mesh_term>Depressive Disorder</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>De-identified data will be shared for further analysis after main results are published.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

